The World Vaccine Congress Washington is a series of conferences and an exhibition designed to promote research, development and strategic partnerships for the global vaccine industry.
The World Vaccine Congress Washington is a series of conferences and an exhibition designed to promote research, development and strategic partnerships for the global vaccine industry.
Taking place 6-9 April in Washington, US, the event has grown over the past 19 years into the world’s biggest and most established global vaccine event with more than 350 speakers.
The event is expected to attract more than 1,500 professionals in the vaccine industry, creating opportunities for hundreds of networking hours.
World Vaccine Congress Washington will explore the complete vaccine value chain.
Key visitors will include government officials, academia, and leading pharma, biotech and small-to-medium-sized enterprise (SME) biotech companies.
World Vaccine Congress Washington delivers a platform where global pharmaceutical service providers and their partners can discuss scientific, clinical and strategic advances and opportunities.
The event has confirmed more than 200 speakers, including representatives from the Merck, the World Health Organization (WHO), Glaxo Smith Klein (GSK) and the National Institute of Health (NIAID).
Global Vaccine Leaders speaking at the event include members of the US the Food and Drug Administration (FDA) and the United States Department of Agriculture (USADA), as well as representatives of companies such as Janssen, Merck Vaccines, Pfizer and Sanofi. Speakers will also be present from schools, including Kinshasa University Medical School, University of Pennsylvania School of Medicine & Vaxconsult, and University of Maryland School of Medicine.
The World Vaccine Congress provides the occasion to hear from more than 350 senior speakers across the spectrum of the vaccine market.
We will have government representatives from WHO, CEPI, European Commission, EMA, FDA to C-level executives from GSK, Merck, Pfizer, Janssen, Sanofi amongst many others.
With more than 1,500 attendees expected, this is a great chance to meet and network with hundreds of like-minded peers at the biggest vaccines meeting in the world.
Attend focused sessions across multiple tracks and ten co-located conferences covering topics from respiratory infections, emerging and infectious diseases, cancer immunotherapy, immune profiling, supply and logistics, manufacture, clinical development, veterinary vaccines, vaccine partnerships and many more.
This year, there will be more networking opportunities than ever, as throughout the three days’ worth of content there are extended breaks and multiple drinks receptions, giving you more time to meet cross-sector contacts.
Similar to the conference itself, the pre-congress workshops will cover a range of topics, including animal health, cancer, adjuvants, antimicrobial resistance and many others.
Some examples of workshops include:
Throughout World Vaccine Congress Washington, companies will be delivering their key messages at thought leader presentations on a chosen topic. These include panel discussions, roundtables, branding promotions, case study presentations, technology showcases.
Exhibition stands also provide companies with access to vaccine industry decision-makers.
Find out more and download the 2020 agenda: www.terrapinn.com/WVCDC/PBR-agenda
or
Visit the site:
www.terrapinn.com/WVCDC/PBR-home
Walter E Washington Congress Center
801 MT Vernon PI NW,
20001 Washington DC
United States